How Purdue’s ‘one-two’ punch grew the opioids market
Accused of exaggerating the benefits of OxyContin, the company’s owners had a bigger share than realised
from International homepage https://ift.tt/2wSEi8v
from International homepage https://ift.tt/2wSEi8v
No comments